| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial.
|
Lancet
|
2010
|
13.59
|
|
2
|
Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium.
|
Proc Natl Acad Sci U S A
|
1996
|
6.42
|
|
3
|
Human immunodeficiency virus infection of cells arrested in the cell cycle.
|
EMBO J
|
1992
|
6.05
|
|
4
|
Environmental regulation of Salmonella pathogenicity island 2 gene expression.
|
Mol Microbiol
|
1999
|
3.78
|
|
5
|
Salmonella pathogenicity islands encoding type III secretion systems.
|
Microbes Infect
|
2001
|
2.49
|
|
6
|
Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya.
|
JAMA
|
1993
|
2.41
|
|
7
|
pH-dependent secretion of SseB, a product of the SPI-2 type III secretion system of Salmonella typhimurium.
|
Mol Microbiol
|
1999
|
2.29
|
|
8
|
Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia.
|
Leukemia
|
2004
|
2.08
|
|
9
|
Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group.
|
J Clin Oncol
|
2003
|
1.86
|
|
10
|
High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia.
|
Leukemia
|
2005
|
1.72
|
|
11
|
Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA.
|
J Infect Dis
|
1994
|
1.70
|
|
12
|
SseBCD proteins are secreted by the type III secretion system of Salmonella pathogenicity island 2 and function as a translocon.
|
J Bacteriol
|
2001
|
1.58
|
|
13
|
Cellular microbiology of intracellular Salmonella enterica: functions of the type III secretion system encoded by Salmonella pathogenicity island 2.
|
Cell Mol Life Sci
|
2004
|
1.55
|
|
14
|
Mutations in Salmonella pathogenicity island 2 (SPI2) genes affecting transcription of SPI1 genes and resistance to antimicrobial agents.
|
J Bacteriol
|
1998
|
1.52
|
|
15
|
Pathogenicity island 2 mutants of Salmonella typhimurium are efficient carriers for heterologous antigens and enable modulation of immune responses.
|
Infect Immun
|
1999
|
1.17
|
|
16
|
Characteristics associated with long-term progression-free survival following high-dose chemotherapy in metastatic breast cancer and influence of chemotherapy dose.
|
Ann Oncol
|
2002
|
1.13
|
|
17
|
Risk-adapted postremission therapy in acute myeloid leukemia: results of the German multicenter AML HD93 treatment trial.
|
Leukemia
|
2003
|
1.08
|
|
18
|
[Integrated skills laboratory concept for undergraduate training in internal medicine].
|
Dtsch Med Wochenschr
|
2005
|
1.05
|
|
19
|
Nitric oxide induces transient Ca2+ changes in endothelial cells independent of cGMP.
|
J Cell Physiol
|
1997
|
0.94
|
|
20
|
Endothelial damage induced by nitric oxide: synergism with reactive oxygen species.
|
Biochem Biophys Res Commun
|
1995
|
0.93
|
|
21
|
Human immunodeficiency virus infection among high-risk seronegative prostitutes in Nairobi.
|
J Infect Dis
|
1993
|
0.92
|
|
22
|
Secretion of MCP-1 and IL-6 by cytokine stimulated production of reactive oxygen species in endothelial cells.
|
Mol Cell Biochem
|
2000
|
0.92
|
|
23
|
Regulation of virulence genes by environmental signals in Salmonella typhimurium.
|
Electrophoresis
|
1999
|
0.91
|
|
24
|
Intensive consolidation versus oral maintenance therapy in patients 61 years or older with acute myeloid leukemia in first remission: results of second randomization of the AML HD98-B treatment Trial.
|
Leukemia
|
2006
|
0.91
|
|
25
|
Characteristics of relapse after autologous stem-cell transplantation for follicular lymphoma: a long-term follow-up.
|
Ann Oncol
|
2009
|
0.88
|
|
26
|
The impact of allogeneic stem cell transplantation on the natural course of poor-risk chronic lymphocytic leukemia as defined by the EBMT consensus criteria: a retrospective donor versus no donor comparison.
|
Ann Oncol
|
2014
|
0.86
|
|
27
|
Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximab.
|
Leukemia
|
2013
|
0.86
|
|
28
|
Transient Ca2+ changes in endothelial cells induced by low doses of reactive oxygen species: role of hydrogen peroxide.
|
Mol Cell Biochem
|
1997
|
0.86
|
|
29
|
Autologous haematopoietic stem cell transplantation for Behcet's disease with pulmonary involvement: analysis after 5 years of follow up.
|
Ann Rheum Dis
|
2005
|
0.83
|
|
30
|
Presence of 14Hz spindle oscillations in the human EEG during deep anesthesia.
|
Clin Neurophysiol
|
2005
|
0.83
|
|
31
|
Chronic lymphocytic leukaemia and concomitant relapsing polychondritis: a report on one treatment for the combined manifestation of two diseases.
|
Rheumatology (Oxford)
|
2005
|
0.82
|
|
32
|
Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia.
|
Leukemia
|
2002
|
0.80
|
|
33
|
Autologous hematopoietic stem-cell transplantation for Behçet's disease with pulmonary involvement.
|
N Engl J Med
|
2001
|
0.80
|
|
34
|
Continuous infusion of ceftazidime for patients with breast cancer and multiple myeloma receiving high-dose chemotherapy and peripheral blood stem cell transplantation.
|
Bone Marrow Transplant
|
2002
|
0.78
|
|
35
|
Hodgkin lymphoma is as common as non-Hodgkin lymphoma in HIV-positive patients with sustained viral suppression and limited immune deficiency: a prospective cohort study.
|
HIV Med
|
2014
|
0.78
|
|
36
|
Intracellular Ca2+ dependence of nitric oxide mediated enhancement of interleukin-8 secretion in human endothelial cells.
|
FEBS Lett
|
1997
|
0.77
|
|
37
|
Infectious complications in chronic lymphoid malignancy.
|
Curr Treat Options Oncol
|
2001
|
0.77
|
|
38
|
[Central induction area. Reduction of non-operative time without additional costs].
|
Anaesthesist
|
2007
|
0.77
|
|
39
|
Prognostic markers for survival after high-dose chemotherapy with autologous stem-cell transplantation for breast cancer.
|
Ann Oncol
|
2003
|
0.75
|
|
40
|
Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemia.
|
Ann Hematol
|
2002
|
0.75
|
|
41
|
Comparison of double and triple high-dose chemotherapy with autologous blood stem cell transplantation in patients with metastatic breast cancer.
|
Stem Cells
|
2001
|
0.75
|
|
42
|
[Continuous "high flux" dialysis: an effective renal replacement therapy for intensive care patients].
|
Zentralbl Chir
|
1997
|
0.75
|
|
43
|
[Non-invasive cardiac output measurement with USCOM in air rescue operation].
|
Ultraschall Med
|
2008
|
0.75
|
|
44
|
[The influence of intraoperative fluid therapy on the postoperative outcome in "fast track" colon surgery].
|
Anasthesiol Intensivmed Notfallmed Schmerzther
|
2006
|
0.75
|
|
45
|
Micrometastatic bone marrow cells at diagnosis have no impact on survival of primary breast cancer patients with extensive axillary lymph node involvement treated with stem cell-supported high-dose chemotherapy.
|
Ann Oncol
|
2004
|
0.75
|
|
46
|
[Preoperative hemodilution as a possibility in autologous blood transfusion. A report of experiences].
|
Zentralbl Chir
|
1991
|
0.75
|
|
47
|
[Mucormycosis in granulocytopenic patients].
|
Med Klin (Munich)
|
1987
|
0.75
|
|
48
|
Final results of a randomized trial comparing 1, 3, or 6 infusions of Rituximab plus 6 cycles CHOP provide valuable preliminary data towards a more cost-effective and safer treatment of advanced follicular lymphoma.
|
Am J Hematol
|
2012
|
0.75
|
|
49
|
Parenteral selenium supplementation in critically ill patients--effects on antioxidant metabolism.
|
Z Ernahrungswiss
|
1998
|
0.75
|
|
50
|
Commercial LightCycler-based quantitative real-time PCR compared to nested PCR for monitoring of Bcl-2/IgH rearrangement in patients with follicular lymphoma.
|
Ann Hematol
|
2008
|
0.75
|
|
51
|
[Oxygen transport in septic patients].
|
Anaesthesist
|
1999
|
0.75
|
|
52
|
Selective neurogenic blockade and perioperative immune reactivity in patients undergoing lung resection.
|
J Int Med Res
|
2012
|
0.75
|
|
53
|
[Immunoglobulins in PID, SID and neurological autoimmune disease].
|
Dtsch Med Wochenschr
|
2012
|
0.75
|